Targeting immunogenic cell death for glioma immunotherapy
Trends in Cancer · 2024-01 · 10 (1) · 8-11
DOI: 10.1016/j.trecan.2023.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Cancer, 2024-01. Verfasst von Tatiana A Mishchenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia. Hauptthemen laut MEDLINE: Glioma, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Immunogenic cell death (ICD) arouses great interest in targeting glioma, the most common primary brain tumor, to achieve boosted immunotherapy. We discuss the unexpected findings on the induction of Th17 immunity by ICD and propose the best design for dendritic cell (DC)-based vaccines loaded with whole glioma lysates obtained after ICD inducers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
- Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia; Neuroscience Research Institute, National Research Lobachevsky State University of Nizhny…
- Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Cancer Research Institut…
Förderung
- Russian Science Foundation
Zitieren
APA
Mishchenko, T. A., Turubanova, V. D., Gorshkova, E. N., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2024). Targeting immunogenic cell death for glioma immunotherapy. Trends in Cancer, 10(1), 8-11. https://doi.org/10.1016/j.trecan.2023.10.005
Vancouver
Mishchenko TA, Turubanova VD, Gorshkova EN, Krysko O, Vedunova MV, Krysko DV. Targeting immunogenic cell death for glioma immunotherapy. Trends in Cancer. 2024;10(1):8-11. doi:10.1016/j.trecan.2023.10.005
BibTeX
@article{Mishchenko2024,
author = {Mishchenko, Tatiana A and Turubanova, Victoria D and Gorshkova, Ekaterina N and Krysko, Olga and Vedunova, Maria V and Krysko, Dmitri V},
title = {Targeting immunogenic cell death for glioma immunotherapy},
journal = {Trends in Cancer},
year = {2024},
volume = {10},
number = {1},
pages = {8--11},
doi = {10.1016/j.trecan.2023.10.005}
}
EUVIMED